Metoclopramide as an Antiemetic in Chemotherapy
- 22 July 1982
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 307 (4) , 249-251
- https://doi.org/10.1056/nejm198207223070413
Abstract
To the Editor: Several papers have been published recently on the usefulness of metoclopramide as an antiemetic in chemotherapy, and a point mentioned by both Gralla et al.1 and Laszlo and Lucas2 (October 15 issue) deserves emphasizing. Although metoclopramide is highly effective against cisplatin, the most emetogenic chemotherapeutic agent to date, it should not be assumed that metoclopramide will be the antiemetic of choice for all chemotherapy-induced nausea and vomiting.There is mounting evidence that chemotherapeutic agents trigger emesis via different or multiple pathways.3 Studies in dogs4 have suggested that a peripheral pathway is the most likely mechanism responsible for . . .Keywords
This publication has 6 references indexed in Scilit:
- Emesis as a Critical Problem in ChemotherapyNew England Journal of Medicine, 1981
- Antiemetic Efficacy of High-Dose Metoclopramide: Randomized Trials with Placebo and Prochlorperazine in Patients with Chemotherapy-Induced Nausea and VomitingNew England Journal of Medicine, 1981
- Antiemetics in Patients Receiving Chemotherapy for CancerNew England Journal of Medicine, 1980
- Incidence of nausea and vomiting with cytotoxic chemotherapy: a prospective randomised trial of antiemetics.BMJ, 1979
- Metoclopramide Metabolism and Determination by High-Pressure Liquid ChromatographyJournal of Pharmaceutical Sciences, 1977
- Cancer Treatment Needs Better AntiemeticsNew England Journal of Medicine, 1975